Post Date: October 3, 2019
The five-year, $28 million grant from the National Center for Advancing Translational Sciences (NCATS), one of the National Institutes of Health, is among the largest ever received by Cincinnati Children’s.
The first year of funding for Cincinnati Children’s role was announced Oct. 3, 2019, along with grants to 20 other research centers participating in the Rare Diseases Clinical Research Network (RDCRN).
The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, diagnosis, or treatment.